Skip to main content

MoneyWorks4Me

Dr Reddys Laboratories informs about press release

12 May 2021 Evaluate
Dr Reddys Laboratories has informed that it has enclosed a Press Release on ‘Dr. Reddy's Laboratories enters into a Voluntary Licensing Agreement with Lilly to Expand Access to Covid-19 Treatment in India.’

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1762.95
Dr. Reddys Labs. 1338.50
Cipla 1357.00
Lupin 1998.00
Zydus Lifesciences 1186.00
View more..